The pharmaceutical industry is an industry that provides medicines related to the health and life of the people. The pharmaceutical industry is a traditional regulation industry with the characteristics of R&D(Research and Development), purchasing, manufacturing, distribution and consumption under strict government management. Until now, pharmaceutical companies have continued to make efforts to maintain competitiveness through patent management, new product development, and marketing. However, industries are rapidly changing, including rising costs for developing new products and expanding generic markets. As these changes and uncertainties in the management environment increase, efforts are required to improve the competitiveness of the pharmaceutical industry from a new perspective. In this study, we intend to examine the impact of SCM(Supply Chain Management) dynamic capability of pharmaceutical companies on corporate performance through partnerships to respond to market changes and uncertainties. It was determined that the agility, visibility and flexibility that constitutes the SCM dynamic capabilities would affect the performance of pharmaceutical companies. In this study, the importance of SCM dynamic capabilities and cooperative relationships was identified through surveys by SCM managers of pharmaceutical companies. Consequently, in the pharmaceutical industry, which is a regulatory industry, we have identified that SCM dynamic capabilities and cooperative relationships with partner companies have a significant impact on corporate performance.

1. 서 론
2. 이론적 배경
    2.1 제약산업
    2.2 SCM 동적역량
    2.3 협력관계
    2.4 경영성과
3. 연구방법
    3.1 연구 모델 및 연구 가설
    3.2 변수의 조작적 정의
    3.3 자료수집방법 및 분석방법
4. 연구결과
    4.1 표본의 특성
    4.2 타당성 분석
    4.3 적합성 분석
    4.4 가설 검증
5. 결 론
References

• Young-Kyu Seo(한양대학교 대학원 경영학과) | 서영규
• Dohan Song(민주연구원) | 송두한
• Hoon Huh(백석예술대학교 경영행정학부) | 허훈 Corresponding Author